Esperion Therapeutics Inc (ESPR)
1.995
-0.04
(-1.72%)
USD |
NASDAQ |
Nov 04, 16:00
2.01
+0.02
(+0.75%)
After-Hours: 20:00
Esperion Therapeutics Profit Margin (Quarterly): -83.87% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -83.87% |
| March 31, 2024 | 44.30% |
| December 31, 2023 | -174.7% |
| September 30, 2023 | -121.4% |
| June 30, 2023 | -193.7% |
| March 31, 2023 | -253.7% |
| December 31, 2022 | -294.9% |
| September 30, 2022 | -290.4% |
| June 30, 2022 | -352.0% |
| March 31, 2022 | -301.2% |
| December 31, 2021 | -422.8% |
| Date | Value |
|---|---|
| September 30, 2021 | -481.5% |
| June 30, 2021 | -107.4% |
| March 31, 2021 | -1.14K% |
| December 31, 2020 | -1.08K% |
| September 30, 2020 | -2.23K% |
| June 30, 2020 | 58.71% |
| March 31, 2020 | -4.25K% |
| December 31, 2019 | -6.31K% |
| September 30, 2019 | -6.97K% |
| June 30, 2019 | -5.52K% |
| March 31, 2019 | 60.09% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-6.31K%
Minimum
Dec 2019
58.71%
Maximum
Jun 2020
-946.7%
Average
-294.9%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Nektar Therapeutics | -222.9% |
| Alaunos Therapeutics Inc | -28.22K% |
| Oragenics Inc | -- |
| Cocrystal Pharma Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -35.50% |
| Gross Profit Margin (Quarterly) | 78.86% |
| Operating Margin (Quarterly) | 3.49% |
| Return on Net Operating Assets | -82.27% |